DM
KBIO

Deerfield Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Deerfield Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-285,848
Closed -$3.96M – 151
2014
Q4 		$3.96M Sell
285,848
-98,524
-26% -$1.41M 0.14% 88
2014
Q3 		$4.77M Buy
384,372
+36,024
+10% +$497K 0.17% 93
2014
Q2 		$6.35M Hold
348,348
– – 0.26% 81
2014
Q1 		$7.55M Buy
+348,348
New +$10.1M 0.31% 78

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Deerfield Management's KBIO Position: Q1 2015 in Review

Deerfield Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 285,848 shares — an estimated $3.96M sold.

Deerfield Management first reported a position in KBIO in Q1 2014 and held it in 4 quarters. The position peaked at $7.55M in Q1 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

  • Deerfield Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
  • Deerfield Management sold 285,848 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $3.96M.
  • Deerfield Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2014 and held it in 4 quarters.
  • Deerfield Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $7.55M in Q1 2014.
  • 24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Deerfield Management's 13F filing for Q1 2015, filed 15 May 2015.